# PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

> **NCT04176497** · PHASE2 · TERMINATED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga-HBED-CC-PSMA

## Key facts

- **NCT ID:** NCT04176497
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-16
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-10-25
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Funding unavailable
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04176497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04176497, "PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04176497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*